Product & regulatory approvals
Gates that opened: regulatory and product approvals — drug approvals, licences, clearances — disclosed to the exchanges inside the window. The approval filing is linked on every row.
| Company | Why it’s here — the filing | Reaction 1d / 1w / 1m | Price | Mcap |
|---|---|---|---|---|
| Mukka Proteins Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals | pending | ₹26.67 | 800 Cr | |
| Patel Retail Limited has informed the Exchange regarding a press release dated February 27, that it has received export authorization for wheat flour and related products from DGFT.". | pending | ₹234 | 780 Cr | |
| SHAREINDIA: Share India Securities Limited has informed the Exchange that the Company has been activated as a Depository Participant of National Securities Depository Limited w.e.f. February 24, 2026. | pending | ₹174 | 3,808 Cr |
Page 5 of 5Previous
How this list is built
A company appears when an NSE/BSE filing inside the last 180 days carries one of these classifier signals (minimum importance: Medium): Regulatory Product Approval. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.
MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.